# ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis

> **NCT03645057** · PHASE3 · COMPLETED · sponsor: **University of Rochester** · enrollment: 92 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Crisaborole
- **DRUG:** Tacrolimus 0.03% Ointment

## Key facts

- **NCT ID:** NCT03645057
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-20
- **Primary completion:** 2021-08-01
- **Final completion:** 2021-08-01
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2022-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03645057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03645057, "ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03645057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*